Carvedilol Phosphate Capsule, Extended Release
Product Images NDC 71335-9707

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carvedilol Phosphate (NDC 71335-9707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Carvedilol 1)

Chemical structure diagram of Carvedilol Phosphate showing its molecular composition including rings, hydroxyl groups, and phosphate and water components.*

FDA Label Image

Figure (Carvedilol 2)

Two line graphs showing the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 24 hours after a morning dose of Carvedilol Phosphate extended-release capsules at 20 mg, 40 mg, and 80 mg strengths. The graphs depict trends for each dosage over time in hours, with lines smoothed using locally weighted regression smoothing methodology.*

FDA Label Image

Label (Lbl713359707)

Label for Carvedilol Phosphate Extended-Release Capsules 20 mg by Bryant Ranch Prepack. The label includes warnings about storage at 25°C, keeping out of children's reach, and seal integrity. The package contains 30 capsules and is repackaged by Bryant Ranch Prepack, Inc. in Burbank, CA, with manufacturing by Frontida BioPharm Inc. NDC 71335-9707-1 is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.